Recursion Pharmaceuticals, Inc. (RXRX)
3.07
-0.08
(-2.54%)
USD |
NASDAQ |
Apr 07, 10:34
Recursion Pharmaceuticals SG&A Expense (TTM) : 176.59M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Intellia Therapeutics, Inc. | 119.80M |
| Tango Therapeutics, Inc. | 41.51M |
| Geron Corp. | 159.26M |
| Ionis Pharmaceuticals, Inc. | 393.68M |
| Quince Therapeutics, Inc. | 15.70M |